Researcher profile
Michael T. Lynskey
Affiliations
Organizations
Christchurch Clinical Studies Trustauthorship · NZChristchurch Hospitalauthorship · NZEdinburgh Collegeauthorship · GBImperial College Londonauthorship · GBInternational Drug Developmentauthorship · FRKing's College Hospitalauthorship · GBKing's College Londonauthorship · GBKing's College - North Carolinaauthorship · USKing's College Schoolauthorship · GBMurdoch Children's Research Instituteauthorship · AUNational Centre for Clinical Research on Emerging Drugsauthorship · AUNational Drug Addiction Centerauthorship · BGQIMR Berghofer Medical Research Instituteauthorship · AUThe University of Queenslandauthorship · AUUniversity of Bathauthorship · GBUniversity of Cambridgeauthorship · GBUniversity of Edinburghauthorship · GBUniversity of Missouriauthorship · USUniversity of the Sunshine Coastauthorship · AUUniversity of Washingtonauthorship · USUNSW Sydneyauthorship · AUWashington University in St. Louisauthorship · US
Public evidence
15 connected articles
The impact of schizophrenia genetic load and heavy cannabis use on the risk of psychotic disorder in the EU-GEI case-control and UK Biobank studies.2024 · Europe PMCMedicinal cannabis for treating post-traumatic stress disorder and comorbid depression: real-world evidence.2024 · Europe PMCAdverse childhood experiences and adolescent cannabis use trajectories: findings from a longitudinal UK birth cohort.2023 · Europe PMC"<i>Flower Power</i>": Controlled Inhalation of THC-Predominant Cannabis Flos Improves Health-Related Quality of Life and Symptoms of Chronic Pain and Anxiety in Eligible UK Patients.2022 · PubMed Central Open AccessClinical withdrawal symptom profile of synthetic cannabinoid receptor agonists and comparison of effects with high potency cannabis.2022 · Europe PMCThe value of real world evidence: The case of medical cannabis.2022 · PubMed Central Open AccessThe Relationship Between Childhood Physical and Sexual Abuse and Adolescent Cannabis Use: A Systematic Review.2021 · PubMed Central Open AccessDaily use of high-potency cannabis is associated with more positive symptoms in first-episode psychosis patients: the EU-GEI case-control study.2021 · PubMed Central Open AccessThe continuity of effect of schizophrenia polygenic risk score and patterns of cannabis use on transdiagnostic symptom dimensions at first-episode psychosis: findings from the EU-GEI study.2021 · PubMed Central Open AccessThe contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study.
Matched by exact identifiers only. Profile data: Corpus/OpenAlex.